Cardiac Renal Failure

Cardiorenal syndrome (CRS) commonly occurs during treatment of acute decompensated heart failure (ADHF) and is associated with poor clinical outcome. The pathophysiology of CRS entails a complex interaction between hemodynamic alterations, including reduced renal perfusion, increased venous pressure and activation of multiple Neurohormonal systems. Attempts to effectively treat congestion while preserving renal function in ADHF are often met with limited clinical success and often require therapeutic decisions that reflect a compromise between potential benefits and harm. Cardio renal syndromes (CRS) have been subdivided into five syndromes representing clinical vignettes in which both the heart and the kidney are involved in bidirectional injury and dysfunction via a final common pathway of cell-to-cell death and accelerated apoptosis mediated by a variety of mechanisms including ischemia, inflammation, and oxidative injury.

  • Hypertension and tachycardia
  • Cardiovascular disease
  • Structural heart disease
  • Cardiac rehabilitation

Related Conference of Cardiac Renal Failure

June 22-23, 2020

5th World Kidney Congress

Abu Dhabi, UAE
August 20-21, 2020

16th World Nephrology Conference

Prague, Czech Republic
September 07-08, 2020

22nd World Nephrologists Summit

Tokyo, Japan
September 14-15, 2020

17th Asia Pacific Nephrology Conference

Osaka, Japan
September 16-17, 2020

15th Nephrology,Renal Medicine & Renal Care

Tokyo, Japan
October 12-13, 2020

24th European Nephrology Conference

Zurich, Switzerland
October 26-27, 2020

3rd International Conference on Nephrology

Dubai, UAE
November 09-10, 2020

International Conference on  Urology and Andrology

Bangkok, Thailand
November 23-24, 2020

World Congress and Expo on Nephrology

Hanoi, Vietnam

Cardiac Renal Failure Conference Speakers

Recommended Sessions

Related Journals

Are you interested in